My Top Growth Stock to Buy in November
I don't like the term "growth stock" all that much. Investors want their money to grow in some shape, form, or fashion with every stock they buy. However, I understand that textbook growth stocks generate market-beating growth that not every stock will deliver.
And I do have several favorite stocks that fit that description. My top growth stock to buy in November is one that I've owned for several years and believe will handily outperform the market over the long term.
Image source: Vertex Pharmaceuticals.
Source Fool.com
Vertex Pharmaceuticals Inc. Aktie
371,65 €
0,53 %
Starke Bevorzugung von Vertex Pharmaceuticals Inc. in der Community mit ausschließlich Buy-Einschätzungen.
Ein Kursziel von 461 € für Vertex Pharmaceuticals Inc. könnte zu einer Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 371.65 € führen.
